THE EFFECT OF CLOFIBRATE ON HYPERBILIRUBINEMIA OF TERM NEONATES

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

HABIBI MORTEZA; ABOLFAZL MAHYAR; AYAZI PARVIZ; AHMADABADI FARZAD; JAVADI AMIR

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: ACTA MEDICA IRANICA Year:2012 | Volume:50 | Issue:1 Page(s): 21-25

Download Full-Text

View:

312

Download:

Cites:

Information Journal Paper

Title

THE EFFECT OF CLOFIBRATE ON HYPERBILIRUBINEMIA OF TERM NEONATES

Author(s)

Keywords

CLOFIBRATE

HYPERBILIRUBINEMIA

NEONATE

Abstract

CLOFIBRATE is a glucuronosyl transferase inducer that has been proposed to increase the elimination of bilirubin in NEONATEs with HYPERBILIRUBINEMIA. This study was conducted to determine the therapeutic effect of CLOFIBRATE in term NEONATEs with non-hemolytic jaundice. This study was conducted on 52 newborns with pathologic unconjugated jaundice in Qazvin children hospital. Newborns divided randomly in two groups.Case group treated with CLOFIBRATE and intensive phototherapy, while control group treated only with intensive phototherapy.Serum bilirubin level was measured before and 6, 12, 24 and 48 hours after treatment.Results were compared and analyzed. The mean serum level of bilirubin before treatment in the case and control groups were 20.78±2.38 and 20.52±2.44 mg/dl, respectively (P=0.69). The mean serum level of bilirubin in 6, 12, 24 and 48 hours after treatment in the case group were 18.20±2.20, 14.70±2.06, 10.72±2.40 and 8.90±0.83 mg/dl, respectively. These values in control group were 18.26±2.42, 15.36±2.59, 12.29±2.28 and 10.23±1.50 mg/dl, respectively. There was significant difference between two groups regarding mean serum level of bilirubin 24 hours (P=0.019) and 48 hours after treatment (P=0.005).In conclusion, CLOFIBRATE was effective in reducing neonatal jaundice and its effect appeared 24 hours after treatment.

Cites

No record.

References

No record.

Cite

APA: Copy

HABIBI, MORTEZA, ABOLFAZL, MAHYAR, AYAZI, PARVIZ, AHMADABADI, FARZAD, & JAVADI, AMIR. (2012). THE EFFECT OF CLOFIBRATE ON HYPERBILIRUBINEMIA OF TERM NEONATES. ACTA MEDICA IRANICA, 50(1), 21-25. SID. https://sid.ir/paper/278527/en

Vancouver: Copy

HABIBI MORTEZA, ABOLFAZL MAHYAR, AYAZI PARVIZ, AHMADABADI FARZAD, JAVADI AMIR. THE EFFECT OF CLOFIBRATE ON HYPERBILIRUBINEMIA OF TERM NEONATES. ACTA MEDICA IRANICA[Internet]. 2012;50(1):21-25. Available from: https://sid.ir/paper/278527/en

IEEE: Copy

MORTEZA HABIBI, MAHYAR ABOLFAZL, PARVIZ AYAZI, FARZAD AHMADABADI, and AMIR JAVADI, “THE EFFECT OF CLOFIBRATE ON HYPERBILIRUBINEMIA OF TERM NEONATES,” ACTA MEDICA IRANICA, vol. 50, no. 1, pp. 21–25, 2012, [Online]. Available: https://sid.ir/paper/278527/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops